Evidence map›Paper›PMID 32781665›Full record

ReviewMetabolites2020

Promoter Architecture and Promoter Engineering in

Hongting Tang, Yanling Wu, Jiliang Deng, Nanzhu Chen, Zhaohui Zheng, Yongjun Wei, Xiaozhou Luo, Jay D Keasling

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Construction of a globally modular recombinantSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. EngineeringFrontiers in microbiology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Systems Metabolic Engineering ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Hongting TangCenter for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Chinese Academy of Sciences, Shenzhen 518055, China.
Yanling WuCenter for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Chinese Academy of Sciences, Shenzhen 518055, China.
Jiliang DengCenter for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Chinese Academy of Sciences, Shenzhen 518055, China.
Nanzhu ChenCenter for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Chinese Academy of Sciences, Shenzhen 518055, China.
Zhaohui ZhengCenter for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Chinese Academy of Sciences, Shenzhen 518055, China.
Yongjun WeiSchool of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.ORCID 0000-0002-1554-1999
Xiaozhou LuoCenter for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Chinese Academy of Sciences, Shenzhen 518055, China.ORCID 0000-0001-9808-6890
Jay D KeaslingCenter for Synthetic Biochemistry, Shenzhen Institutes for Advanced Technologies, Chinese Academy of Sciences, Shenzhen 518055, China.
Chinese Academy of Sciences · CNLawrence Berkeley National Laboratory · USZhengzhou University · CN

Funding

National Key Research and Development of China 2018YFA0903200National Natural Science Foundation of China 3180079Shenzhen Institute of Synthetic Biology Scientific Research Program DWKF20190004
6 · The paper itself

Abstract

Promoters play an essential role in the regulation of gene expression for fine-tuning genetic circuits and metabolic pathways in

Indexed as

machine learningpromoter architecturepromoter engineeringSaccharomyces cerevisiaesynthetic biologysynthetic promoter

Identifiers

PMID32781665
PMCPMC7466126
OpenAlexW3047569587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.